We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Advances in Phenotypic Screening: A Turning Point for Drug Discovery?

Article   Jul 14, 2020 | By Michele Wilson, PhD

 
Advances in Phenotypic Screening: A Turning Point for Drug Discovery?

Human colorectal cancer cells treated with a topoisomerase inhibitor and an inhibitor of the protein kinase ATR. Cell nuclei (blue), DNA damage (red), foci of DNA replication (green). Credit: Yves Pommier, Rozenn Josse, NCI Center for Cancer Research.

 
 
Advertisement
 

RELATED ARTICLES

The Coronavirus Outbreak

Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

READ MORE

Top Tips for Selecting a Custom Manufacturing Partner

Article

With life science industries facing increased competition, global regulatory demands, and pressure to shorten time to market, outsourcing part – or all – manufacturing is becoming increasingly prevalent. But what should be considered in choosing such a custom or contract manufacturing partner?

READ MORE

Could a Bioartificial Liver System Help To Treat Acute Liver Failure?

Article

Researchers recently reported in Science Translational Medicine the development of a cell-based extracorporeal bioartificial liver system. In this interview, Professor Hexin Yan tells us more about the study and its implications.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE